Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation

Authors :: Seiffge, D.J. Paciaroni, M. Wilson, D. Koga, M. Macha, K. Cappellari, M. Schaedelin, S. Shakeshaft, C. Takagi, M. Tsivgoulis, G. Bonetti, B. Kallmünzer, B. Arihiro, S. Alberti, A. Polymeris, A.A. Ambler, G. Yoshimura, S. Venti, M. Bonati, L.H. Muir, K.W. Yamagami, H. Thilemann, S. Altavilla, R. Peters, N. Inoue, M. Bobinger, T. Agnelli, G. Brown, M.M. Sato, S. Acciarresi, M. Jager, H.R. Bovi, P. Schwab, S. Lyrer, P. Caso, V. Toyoda, K. Werring, D.J. Engelter, S.T. De Marchis, G.M. on behalf of the CROMIS-2, RAF, RAF-DOAC, SAMURAI, NOACISP LONGTERM, Erlangen Verona registry collaborators
Publication Year :: 2019
Abstract: Objective: We compared outcomes after treatment with direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) in patients with atrial fibrillation (AF) and a recent cerebral ischemia. Methods: We conducted an individual patient data analysis of seven prospective cohort studies. We included patients with AF and a recent cerebral ischemia (

Tools